The safety and the results of using living donors above the age of 60 years were studied. In 235 consecutive donors the complications were not different in elderly (n = 70) compared to younger donors. Graft survival and function were studied in 232 consecutive 1-HLA-haplotype mismatched grafts. Graf
Consensus conference on living donor renal transplantation
β Scribed by P. Conlon; D. Cusack; P. McClean; M. Irvine; C. Magee; B. McGovern; L. Plant; D. Gill; D. Smith; M. Akyol; P. Franklin; M. Waldron; Dilly Little; J. Douglas; D. Hickey; D. Murphy; M. Donovan; A. McAuley
- Publisher
- Springer-Verlag
- Year
- 2005
- Tongue
- English
- Weight
- 113 KB
- Volume
- 174
- Category
- Article
- ISSN
- 1863-4362
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We read with interest the article by Thuluvath and Yoo comparing graft and patient survival in adult living donor liver transplant recipients (LDLT) to deceased donor recipients. 1 Using data from 1988 -2001 from the United Network for Organ Sharing database, they found lower graft survival in the L
We read with interest the article by Thuluvath and Yoo comparing graft and patient survival in adult living donor liver transplant recipients (LDLT) to deceased donor recipients. 1 Using data from 1988 -2001 from the United Network for Organ Sharing database, they found lower graft survival in the L
The purpose of this study is to find out whether basiliximab administration will improve postoperative renal function by delaying the start of tacrolimus and decreasing of dosage requirement for tacrolimus in adult living donor liver transplantation (LDLT). Forty-five adult LDLT recipients were enro